35.3 C
Jalandhar
Wednesday, August 26, 2026
HomeNewsFinanceMarket Watch: Top Three Stocks Witnessing Massive Buyer Demand in Today’s Pre-Opening...

Related stories

Fix Soggy Rice: The Simple Kitchen Bread Trick to Save Overcooked Grains

Cooking rice seems like a straightforward kitchen task, but...

Government Lifts Export Restrictions on Wheat Flour, Atta, Maida, and Rava

The Central Government has officially revised its trade policy...

Flipkart Prepares to Launch Food Delivery App with 300 Bengaluru Restaurants

Strategic Entry into Food Delivery E-commerce titan Flipkart is set...

Canada Suspends Trade Talks with US: PM Mark Carney Calls Terms “Unfair and Uneconomic” as $20 Billion Tariff Threat Looms

Breakdown in US-Canada Bilateral Negotiations Canadian Prime Minister Mark Carney...

Tragic Road Accident Near Phillaur Claims Lives of Husband, Wife, and Daughter

Devastating Collision Near Haripur Khalsa Gate Ends Family’s Pilgrimage...

Market Watch: Top Three Stocks Witnessing Massive Buyer Demand in Today’s Pre-Opening Session

Date:

Sensex Starts Flat Amid Selective Sectoral Gains

The Indian equity benchmark indices started on a relatively quiet note today, with the frontline index S&P BSE Sensex opening marginally in the red, down 30.89 points or 0.04 percent. Despite a sluggish overall start for the broader market, investors showed clear preferences during the early trade. On the sectoral front, selective buying emerged immediately. Metals gained 0.25 percent, the power sector zoomed up by 0.26 percent, and auto stocks experienced a quick surge of 0.17 percent, showcasing pocketed strengths in cyclical and core sectors during the pre-opening bell.

Alembic Pharmaceuticals Surges on USFDA Approval

Alembic Pharmaceuticals Ltd stood out as the leading gainer among S&P BSE companies during the pre-opening session. The pharmaceutical major witnessed its share price surge by 5.96 percent, climbing up to trade at Rs 1,029.75 apiece. This strong upward momentum was directly triggered by a major regulatory milestone. The company announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Doxorubicin Hydrochloride Liposome Injection. This crucial approval opens up expanded commercial avenues for the company in the lucrative US market, sparking heavy demand from institutional and retail buyers alike.

SBFC Finance Rides Strong Market Momentum

Another prominent mover in the early session was SBFC Finance Ltd. The non-banking financial company (NBFC) grabbed investor attention as its stock price gained 4.27 percent, trading at Rs 111.15 per share. Interestingly, the company has not released any regulatory filings or major corporate announcements over the last few days. Market analysts suggest that the sudden rally and heavy trading volume in SBFC Finance are being driven purely by strong underlying market forces, favorable liquidity, and technical breakout buying as investors look for high-growth financial stocks.

Metro Brands Gains Solid Footing in Early Trade

Footwear retail giant Metro Brands Ltd also secured its spot among the top three gainers on the BSE during the pre-opening hours. The company’s stock value rose by 3.23 percent, reaching Rs 1,172.75 apiece. Similar to SBFC Finance, Metro Brands did not have any immediate corporate announcements or material events on the exchanges today. The upward movement is attributed to general market dynamics, solid retail sector sentiment, and institutional buyers building up fresh positions at current support levels, confirming robust consumer discretionary demand.

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories